S'abonner

Evolution pathways of IgE responses to grass and mite allergens throughout childhood - 04/12/15

Doi : 10.1016/j.jaci.2015.03.041 
Adnan Custovic, MD, PhD a, , Hans-Joachim Sonntag, MRes a, b, , Iain E. Buchan, MD, PhD b, Danielle Belgrave, PhD a, b, Angela Simpson, MD, PhD a, Mattia C.F. Prosperi, PhD a, b,
a Centre for Respiratory Medicine and Allergy, Institute of Inflammation and Repair, University of Manchester & University Hospital of South Manchester, Manchester, United Kingdom 
b Centre for Health Informatics, Institute of Population Health, University of Manchester, Manchester, United Kingdom 

Corresponding author: Mattia C. F. Prosperi, PhD, Centre for Health Informatics (CHI), Institute of Population Health, University of Manchester, Jean McFarlane Bldg, 1st Floor, Rm 1.314, University Place, Oxford Road, Manchester M13 9PL, United Kingdom.

Abstract

Background

Little is known about longitudinal patterns of the development of IgE to distinct allergen components.

Objective

We sought to investigate the evolution of IgE responses to allergenic components of timothy grass and dust mite during childhood.

Methods

In a population-based birth cohort (n = 1184) we measured IgE responses to 15 components from timothy grass and dust mite in children with available samples at 3 time points (ages 5, 8, and 11 years; n = 235). We designed a nested, 2-stage latent class analysis to identify cross-sectional sensitization patterns at each follow-up and their longitudinal trajectories. We then ascertained the association of longitudinal trajectories with asthma, rhinitis, eczema, and lung function in children with component data for at least 2 time points (n = 534).

Results

Longitudinal latent class analysis revealed 3 grass sensitization trajectories: (1) no/low sensitization; (2) early onset; and (3) late onset. The early-onset trajectory was associated with asthma and diminished lung function, and the late-onset trajectory was associated with rhinitis. Four longitudinal trajectories emerged for mite: (1) no/low sensitization; (2) group 1 allergens; (3) group 2 allergens; and (3) complete mite sensitization. Children in the complete mite sensitization trajectory had the highest odds ratios (ORs) for asthma (OR, 7.15; 95% CI, 3.80-13.44) and were the only group significantly associated with comorbid asthma, rhinitis, and eczema (OR, 5.91; 95% CI, 2.01-17.37). Among children with wheezing, those in the complete mite sensitization trajectory (but not other longitudinal mite trajectories) had significantly higher risk of severe exacerbations (OR, 3.39; 95% CI, 1.62-6.67).

Conclusions

The nature of developmental longitudinal trajectories of IgE responses differed between grass and mite allergen components, with temporal differences (early vs late onset) dominant in grass and diverging patterns of IgE responses (group 1 allergens, group 2 allergens, or both) in mite. Different longitudinal patterns bear different associations with clinical outcomes, which varied by allergen.

Le texte complet de cet article est disponible en PDF.

Key words : IgE, childhood, component-resolved diagnostics, latent class analysis, allergens, dust mite, timothy grass, asthma, wheeze, rhinitis

Abbreviations used : ATS, CRD, eNO, FVC, ISAC, ISU, LCA, MAAS, OR, sIgE


Plan


 MAAS is supported by grants from the J P Moulton Charitable Foundation and Medical Research Council (MRC) grants G0601361 and MR/K002449/1. This study was partly supported by MRC Health eResearch Centre (HeRC) grant MR/K006665/1.
 Disclosure of potential conflict of interest: This study was partly supported by an MRC Health eResearch Centre (HeRC) grant (MR/K006665/1). A. Custovic has received personal fees from Novartis, Thermo Fisher, AstraZeneca, ALK-Abelló, and GlaxoSmithKline. I. E. Buchan's institution has received funding from the Medical Research Council, as has that of M. C. F. Prosperi. D. Belgrave is an employee of GlaxoSmithKline. A. Simpson's institution has received funding from the Medical Research Council, the JP Moulton Charitable Foundation, the North West Lung Centre Charity, the European Union, and the National Institute of Health Research; she has received consultancy fees from Thermo Fisher Scientific and has received payment for delivering lectures from GlaxoSmithKline and Chiesi and has received compensation for travel and other meeting-related expenses from GlaxoSmithKline. H.-J. Sonntag declares that he has no other relevant conflicts of interest.


© 2015  The Authors. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 136 - N° 6

P. 1645 - décembre 2015 Retour au numéro
Article précédent Article précédent
  • Thymic stromal lymphopoietin activation of basophils in patients with allergic asthma is IL-3 dependent
  • Brittany M. Salter, John Paul Oliveria, Graeme Nusca, Steve G. Smith, Rick M. Watson, Micheal Comeau, Roma Sehmi, Gail M. Gauvreau
| Article suivant Article suivant
  • IL-2 is a critical regulator of group 2 innate lymphoid cell function during pulmonary inflammation
  • Ben Roediger, Ryan Kyle, Szun S. Tay, Andrew J. Mitchell, Holly A. Bolton, Thomas V. Guy, Sioh-Yang Tan, Elizabeth Forbes-Blom, Philip L. Tong, Yasmin Köller, Elena Shklovskaya, Makio Iwashima, Kathy D. McCoy, Graham Le Gros, Barbara Fazekas de St Groth, Wolfgang Weninger

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2025 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.